nodes	percent_of_prediction	percent_of_DWPC	metapath
Erythromycin—ABCC1—Etoposide—brain cancer	0.177	0.234	CbGbCtD
Erythromycin—CYP1A2—Carmustine—brain cancer	0.164	0.218	CbGbCtD
Erythromycin—CYP3A4—Temozolomide—brain cancer	0.124	0.165	CbGbCtD
Erythromycin—CYP3A4—Lomustine—brain cancer	0.106	0.14	CbGbCtD
Erythromycin—CYP3A5—Etoposide—brain cancer	0.0654	0.0869	CbGbCtD
Erythromycin—CYP1A2—Etoposide—brain cancer	0.0487	0.0647	CbGbCtD
Erythromycin—ABCB1—Etoposide—brain cancer	0.0426	0.0566	CbGbCtD
Erythromycin—CYP3A4—Etoposide—brain cancer	0.0255	0.0339	CbGbCtD
Erythromycin—Hepatotoxicity—Lomustine—brain cancer	0.00789	0.0479	CcSEcCtD
Erythromycin—Eruption—Hydroxyurea—brain cancer	0.00487	0.0295	CcSEcCtD
Erythromycin—Hearing impaired—Procarbazine—brain cancer	0.00406	0.0247	CcSEcCtD
Erythromycin—Hepatotoxicity—Hydroxyurea—brain cancer	0.00388	0.0235	CcSEcCtD
Erythromycin—Burning sensation—Carmustine—brain cancer	0.00348	0.0211	CcSEcCtD
Erythromycin—Tenderness—Hydroxyurea—brain cancer	0.00343	0.0208	CcSEcCtD
Erythromycin—Hepatic function abnormal—Procarbazine—brain cancer	0.00321	0.0195	CcSEcCtD
Erythromycin—Deafness—Procarbazine—brain cancer	0.00314	0.019	CcSEcCtD
Erythromycin—Hepatotoxicity—Carmustine—brain cancer	0.00313	0.019	CcSEcCtD
Erythromycin—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.00312	0.0394	CbGpPWpGaD
Erythromycin—Hepatotoxicity—Temozolomide—brain cancer	0.00303	0.0184	CcSEcCtD
Erythromycin—Troleandomycin—CYP2C9—brain cancer	0.00292	1	CrCbGaD
Erythromycin—Skin exfoliation—Hydroxyurea—brain cancer	0.00286	0.0173	CcSEcCtD
Erythromycin—CYP3A7—Xenobiotics—CYP2C9—brain cancer	0.00262	0.033	CbGpPWpGaD
Erythromycin—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.00253	0.0153	CcSEcCtD
Erythromycin—Hearing impaired—Temozolomide—brain cancer	0.00246	0.0149	CcSEcCtD
Erythromycin—Hepatotoxicity—Etoposide—brain cancer	0.00242	0.0147	CcSEcCtD
Erythromycin—Pancreatitis—Procarbazine—brain cancer	0.00238	0.0144	CcSEcCtD
Erythromycin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00237	0.0299	CbGpPWpGaD
Erythromycin—Skin exfoliation—Carmustine—brain cancer	0.00231	0.014	CcSEcCtD
Erythromycin—Skin exfoliation—Temozolomide—brain cancer	0.00223	0.0135	CcSEcCtD
Erythromycin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00216	0.0272	CbGpPWpGaD
Erythromycin—Pain—Carboplatin—brain cancer	0.00212	0.0129	CcSEcCtD
Erythromycin—Jaundice—Procarbazine—brain cancer	0.00211	0.0128	CcSEcCtD
Erythromycin—Anorexia—Lomustine—brain cancer	0.00207	0.0126	CcSEcCtD
Erythromycin—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.00194	0.0244	CbGpPWpGaD
Erythromycin—Hallucination—Procarbazine—brain cancer	0.00193	0.0117	CcSEcCtD
Erythromycin—Injury—Carmustine—brain cancer	0.00191	0.0116	CcSEcCtD
Erythromycin—Deafness—Temozolomide—brain cancer	0.0019	0.0115	CcSEcCtD
Erythromycin—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.00189	0.0238	CbGpPWpGaD
Erythromycin—Decreased appetite—Lomustine—brain cancer	0.00189	0.0115	CcSEcCtD
Erythromycin—Pancreatitis—Hydroxyurea—brain cancer	0.00184	0.0112	CcSEcCtD
Erythromycin—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.00182	0.0229	CbGpPWpGaD
Erythromycin—Skin exfoliation—Etoposide—brain cancer	0.00179	0.0108	CcSEcCtD
Erythromycin—Arrhythmia—Procarbazine—brain cancer	0.00174	0.0105	CcSEcCtD
Erythromycin—Liver function test abnormal—Carmustine—brain cancer	0.00162	0.00984	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.00153	0.00928	CcSEcCtD
Erythromycin—Hallucination—Hydroxyurea—brain cancer	0.0015	0.00908	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—PTCH2—brain cancer	0.00147	0.0186	CbGpPWpGaD
Erythromycin—Convulsion—Procarbazine—brain cancer	0.00147	0.00889	CcSEcCtD
Erythromycin—MLNR—G alpha (q) signalling events—TRPC6—brain cancer	0.00145	0.0183	CbGpPWpGaD
Erythromycin—ABCC1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00144	0.0182	CbGpPWpGaD
Erythromycin—Confusional state—Procarbazine—brain cancer	0.00139	0.00844	CcSEcCtD
Erythromycin—Vomiting—Lomustine—brain cancer	0.00138	0.00839	CcSEcCtD
Erythromycin—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00133	0.0168	CbGpPWpGaD
Erythromycin—Anorexia—Procarbazine—brain cancer	0.00132	0.00798	CcSEcCtD
Erythromycin—Erythema—Hydroxyurea—brain cancer	0.00131	0.00794	CcSEcCtD
Erythromycin—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.0013	0.0164	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.0013	0.0164	CbGpPWpGaD
Erythromycin—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.0013	0.00787	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—OR4C12—brain cancer	0.00129	0.0163	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—OR14C36—brain cancer	0.00129	0.0163	CbGpPWpGaD
Erythromycin—Nausea—Lomustine—brain cancer	0.00129	0.00783	CcSEcCtD
Erythromycin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00127	0.016	CbGpPWpGaD
Erythromycin—Toxic epidermal necrolysis—Etoposide—brain cancer	0.00122	0.00742	CcSEcCtD
Erythromycin—Hallucination—Carmustine—brain cancer	0.00121	0.00734	CcSEcCtD
Erythromycin—Decreased appetite—Procarbazine—brain cancer	0.0012	0.00728	CcSEcCtD
Erythromycin—Pain—Procarbazine—brain cancer	0.00118	0.00716	CcSEcCtD
Erythromycin—Hepatitis—Temozolomide—brain cancer	0.00117	0.00713	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—OR4C12—brain cancer	0.00117	0.0148	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—OR14C36—brain cancer	0.00117	0.0148	CbGpPWpGaD
Erythromycin—Hallucination—Temozolomide—brain cancer	0.00117	0.00709	CcSEcCtD
Erythromycin—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.00114	0.0144	CbGpPWpGaD
Erythromycin—Feeling abnormal—Procarbazine—brain cancer	0.00114	0.0069	CcSEcCtD
Erythromycin—Convulsion—Hydroxyurea—brain cancer	0.00113	0.00688	CcSEcCtD
Erythromycin—Gastrointestinal pain—Procarbazine—brain cancer	0.00113	0.00685	CcSEcCtD
Erythromycin—Erythema multiforme—Temozolomide—brain cancer	0.00111	0.00674	CcSEcCtD
Erythromycin—Discomfort—Hydroxyurea—brain cancer	0.0011	0.00668	CcSEcCtD
Erythromycin—Urticaria—Procarbazine—brain cancer	0.0011	0.00665	CcSEcCtD
Erythromycin—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.0011	0.0138	CbGpPWpGaD
Erythromycin—Tinnitus—Temozolomide—brain cancer	0.0011	0.00664	CcSEcCtD
Erythromycin—Abdominal pain—Procarbazine—brain cancer	0.00109	0.00662	CcSEcCtD
Erythromycin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00109	0.0137	CbGpPWpGaD
Erythromycin—Arrhythmia—Carmustine—brain cancer	0.00109	0.00659	CcSEcCtD
Erythromycin—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00107	0.0135	CbGpPWpGaD
Erythromycin—ABCC1—Irinotecan Pathway—APC—brain cancer	0.00106	0.0133	CbGpPWpGaD
Erythromycin—Erythema—Carmustine—brain cancer	0.00106	0.00642	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00104	0.0063	CcSEcCtD
Erythromycin—Erythema—Temozolomide—brain cancer	0.00102	0.0062	CcSEcCtD
Erythromycin—Jaundice—Etoposide—brain cancer	0.00102	0.00619	CcSEcCtD
Erythromycin—Anorexia—Hydroxyurea—brain cancer	0.00102	0.00618	CcSEcCtD
Erythromycin—Hypersensitivity—Procarbazine—brain cancer	0.00102	0.00617	CcSEcCtD
Erythromycin—Dysgeusia—Temozolomide—brain cancer	0.001	0.00607	CcSEcCtD
Erythromycin—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00098	0.0124	CbGpPWpGaD
Erythromycin—Pruritus—Procarbazine—brain cancer	0.000977	0.00592	CcSEcCtD
Erythromycin—Diarrhoea—Procarbazine—brain cancer	0.000944	0.00573	CcSEcCtD
Erythromycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000934	0.0118	CbGpPWpGaD
Erythromycin—Decreased appetite—Hydroxyurea—brain cancer	0.000929	0.00563	CcSEcCtD
Erythromycin—Vertigo—Temozolomide—brain cancer	0.000919	0.00557	CcSEcCtD
Erythromycin—Convulsion—Carmustine—brain cancer	0.000917	0.00556	CcSEcCtD
Erythromycin—Pain—Hydroxyurea—brain cancer	0.000913	0.00554	CcSEcCtD
Erythromycin—Dizziness—Procarbazine—brain cancer	0.000913	0.00554	CcSEcCtD
Erythromycin—Palpitations—Temozolomide—brain cancer	0.000904	0.00548	CcSEcCtD
Erythromycin—Chest pain—Carmustine—brain cancer	0.000901	0.00546	CcSEcCtD
Erythromycin—Erythema multiforme—Etoposide—brain cancer	0.000889	0.00539	CcSEcCtD
Erythromycin—Convulsion—Temozolomide—brain cancer	0.000886	0.00537	CcSEcCtD
Erythromycin—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000881	0.0111	CbGpPWpGaD
Erythromycin—Feeling abnormal—Hydroxyurea—brain cancer	0.00088	0.00534	CcSEcCtD
Erythromycin—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.00088	0.0111	CbGpPWpGaD
Erythromycin—Vomiting—Procarbazine—brain cancer	0.000878	0.00532	CcSEcCtD
Erythromycin—Confusional state—Carmustine—brain cancer	0.000871	0.00528	CcSEcCtD
Erythromycin—Rash—Procarbazine—brain cancer	0.00087	0.00528	CcSEcCtD
Erythromycin—Discomfort—Temozolomide—brain cancer	0.00086	0.00522	CcSEcCtD
Erythromycin—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000846	0.0107	CbGpPWpGaD
Erythromycin—Confusional state—Temozolomide—brain cancer	0.000841	0.0051	CcSEcCtD
Erythromycin—Anaphylactic shock—Temozolomide—brain cancer	0.000834	0.00506	CcSEcCtD
Erythromycin—Anorexia—Carmustine—brain cancer	0.000823	0.00499	CcSEcCtD
Erythromycin—Nausea—Procarbazine—brain cancer	0.00082	0.00497	CcSEcCtD
Erythromycin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000804	0.0101	CbGpPWpGaD
Erythromycin—Dysgeusia—Etoposide—brain cancer	0.000801	0.00486	CcSEcCtD
Erythromycin—Anorexia—Temozolomide—brain cancer	0.000795	0.00483	CcSEcCtD
Erythromycin—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000793	0.01	CbGpPWpGaD
Erythromycin—Hypersensitivity—Hydroxyurea—brain cancer	0.000787	0.00477	CcSEcCtD
Erythromycin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000786	0.0099	CbGpPWpGaD
Erythromycin—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000775	0.00977	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—SHH—brain cancer	0.000759	0.00957	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—PTCH2—brain cancer	0.000756	0.00953	CbGpPWpGaD
Erythromycin—Decreased appetite—Carmustine—brain cancer	0.000751	0.00455	CcSEcCtD
Erythromycin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000745	0.0094	CbGpPWpGaD
Erythromycin—Pain—Carmustine—brain cancer	0.000738	0.00448	CcSEcCtD
Erythromycin—Vertigo—Etoposide—brain cancer	0.000735	0.00446	CcSEcCtD
Erythromycin—Diarrhoea—Hydroxyurea—brain cancer	0.000731	0.00443	CcSEcCtD
Erythromycin—Decreased appetite—Temozolomide—brain cancer	0.000725	0.0044	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—PTCH1—brain cancer	0.00072	0.00907	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—SMO—brain cancer	0.00072	0.00907	CbGpPWpGaD
Erythromycin—Pain—Temozolomide—brain cancer	0.000714	0.00433	CcSEcCtD
Erythromycin—Feeling abnormal—Carmustine—brain cancer	0.000712	0.00432	CcSEcCtD
Erythromycin—Convulsion—Etoposide—brain cancer	0.000709	0.0043	CcSEcCtD
Erythromycin—Dizziness—Hydroxyurea—brain cancer	0.000706	0.00429	CcSEcCtD
Erythromycin—Gastrointestinal pain—Carmustine—brain cancer	0.000706	0.00428	CcSEcCtD
Erythromycin—Chest pain—Etoposide—brain cancer	0.000697	0.00423	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—OR4C12—brain cancer	0.000693	0.00874	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—OR14C36—brain cancer	0.000693	0.00874	CbGpPWpGaD
Erythromycin—Discomfort—Etoposide—brain cancer	0.000688	0.00418	CcSEcCtD
Erythromycin—Feeling abnormal—Temozolomide—brain cancer	0.000688	0.00417	CcSEcCtD
Erythromycin—Abdominal pain—Carmustine—brain cancer	0.000683	0.00414	CcSEcCtD
Erythromycin—Gastrointestinal pain—Temozolomide—brain cancer	0.000682	0.00414	CcSEcCtD
Erythromycin—Vomiting—Hydroxyurea—brain cancer	0.000679	0.00412	CcSEcCtD
Erythromycin—Rash—Hydroxyurea—brain cancer	0.000674	0.00409	CcSEcCtD
Erythromycin—Confusional state—Etoposide—brain cancer	0.000673	0.00408	CcSEcCtD
Erythromycin—Anaphylactic shock—Etoposide—brain cancer	0.000668	0.00405	CcSEcCtD
Erythromycin—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000667	0.00841	CbGpPWpGaD
Erythromycin—Urticaria—Temozolomide—brain cancer	0.000663	0.00402	CcSEcCtD
Erythromycin—Abdominal pain—Temozolomide—brain cancer	0.00066	0.004	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—ABR—brain cancer	0.000653	0.00824	CbGpPWpGaD
Erythromycin—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000652	0.00821	CbGpPWpGaD
Erythromycin—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000637	0.00803	CbGpPWpGaD
Erythromycin—Anorexia—Etoposide—brain cancer	0.000637	0.00386	CcSEcCtD
Erythromycin—Hypersensitivity—Carmustine—brain cancer	0.000636	0.00386	CcSEcCtD
Erythromycin—Nausea—Hydroxyurea—brain cancer	0.000634	0.00385	CcSEcCtD
Erythromycin—Hypersensitivity—Temozolomide—brain cancer	0.000615	0.00373	CcSEcCtD
Erythromycin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000604	0.00761	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—ABR—brain cancer	0.000593	0.00748	CbGpPWpGaD
Erythromycin—Diarrhoea—Carmustine—brain cancer	0.000591	0.00358	CcSEcCtD
Erythromycin—Pruritus—Temozolomide—brain cancer	0.00059	0.00358	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—DTX2—brain cancer	0.000589	0.00743	CbGpPWpGaD
Erythromycin—Decreased appetite—Etoposide—brain cancer	0.00058	0.00352	CcSEcCtD
Erythromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000575	0.00725	CbGpPWpGaD
Erythromycin—Dizziness—Carmustine—brain cancer	0.000571	0.00346	CcSEcCtD
Erythromycin—Pain—Etoposide—brain cancer	0.000571	0.00346	CcSEcCtD
Erythromycin—Diarrhoea—Temozolomide—brain cancer	0.000571	0.00346	CcSEcCtD
Erythromycin—Dizziness—Temozolomide—brain cancer	0.000552	0.00335	CcSEcCtD
Erythromycin—Feeling abnormal—Etoposide—brain cancer	0.00055	0.00334	CcSEcCtD
Erythromycin—Vomiting—Carmustine—brain cancer	0.000549	0.00333	CcSEcCtD
Erythromycin—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000548	0.0069	CbGpPWpGaD
Erythromycin—Gastrointestinal pain—Etoposide—brain cancer	0.000546	0.00331	CcSEcCtD
Erythromycin—Rash—Carmustine—brain cancer	0.000544	0.0033	CcSEcCtD
Erythromycin—Vomiting—Temozolomide—brain cancer	0.000531	0.00322	CcSEcCtD
Erythromycin—Urticaria—Etoposide—brain cancer	0.00053	0.00322	CcSEcCtD
Erythromycin—Abdominal pain—Etoposide—brain cancer	0.000528	0.0032	CcSEcCtD
Erythromycin—Rash—Temozolomide—brain cancer	0.000526	0.00319	CcSEcCtD
Erythromycin—Nausea—Carmustine—brain cancer	0.000513	0.00311	CcSEcCtD
Erythromycin—ABCC1—S1P1 pathway—VEGFA—brain cancer	0.000496	0.00625	CbGpPWpGaD
Erythromycin—Nausea—Temozolomide—brain cancer	0.000496	0.00301	CcSEcCtD
Erythromycin—Hypersensitivity—Etoposide—brain cancer	0.000492	0.00298	CcSEcCtD
Erythromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000473	0.00596	CbGpPWpGaD
Erythromycin—Pruritus—Etoposide—brain cancer	0.000472	0.00287	CcSEcCtD
Erythromycin—CYP3A7—Biological oxidations—CYP2C9—brain cancer	0.000468	0.0059	CbGpPWpGaD
Erythromycin—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000467	0.00589	CbGpPWpGaD
Erythromycin—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	0.000462	0.00582	CbGpPWpGaD
Erythromycin—Diarrhoea—Etoposide—brain cancer	0.000457	0.00277	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—PTCH2—brain cancer	0.000447	0.00563	CbGpPWpGaD
Erythromycin—Dizziness—Etoposide—brain cancer	0.000442	0.00268	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—HES5—brain cancer	0.000433	0.00545	CbGpPWpGaD
Erythromycin—Vomiting—Etoposide—brain cancer	0.000425	0.00258	CcSEcCtD
Erythromycin—Rash—Etoposide—brain cancer	0.000421	0.00255	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—STRADA—brain cancer	0.00042	0.00529	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—TRPC6—brain cancer	0.000414	0.00521	CbGpPWpGaD
Erythromycin—Nausea—Etoposide—brain cancer	0.000397	0.00241	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—SHH—brain cancer	0.00039	0.00491	CbGpPWpGaD
Erythromycin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000384	0.00484	CbGpPWpGaD
Erythromycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000382	0.00481	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—TRPC6—brain cancer	0.000376	0.00473	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—PTCH1—brain cancer	0.000369	0.00465	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—SMO—brain cancer	0.000369	0.00465	CbGpPWpGaD
Erythromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000365	0.0046	CbGpPWpGaD
Erythromycin—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00036	0.00454	CbGpPWpGaD
Erythromycin—SLC22A7—Fluoropyrimidine Activity—TP53—brain cancer	0.000359	0.00452	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—S100A10—brain cancer	0.000352	0.00444	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—ABR—brain cancer	0.000351	0.00442	CbGpPWpGaD
Erythromycin—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000346	0.00436	CbGpPWpGaD
Erythromycin—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000341	0.0043	CbGpPWpGaD
Erythromycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.00034	0.00429	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—GLI2—brain cancer	0.000339	0.00427	CbGpPWpGaD
Erythromycin—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000338	0.00426	CbGpPWpGaD
Erythromycin—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000334	0.00421	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.000332	0.00419	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—GLI1—brain cancer	0.000318	0.00401	CbGpPWpGaD
Erythromycin—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.00031	0.00391	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—VAV1—brain cancer	0.00031	0.00391	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—SUFU—brain cancer	0.000302	0.0038	CbGpPWpGaD
Erythromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000296	0.00373	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—GFAP—brain cancer	0.000291	0.00367	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—VAV1—brain cancer	0.000281	0.00355	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—HEY1—brain cancer	0.000276	0.00348	CbGpPWpGaD
Erythromycin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000275	0.00347	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—DLL1—brain cancer	0.000271	0.00341	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000263	0.00331	CbGpPWpGaD
Erythromycin—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000253	0.00318	CbGpPWpGaD
Erythromycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000238	0.003	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000236	0.00298	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—SHH—brain cancer	0.00023	0.0029	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000229	0.00289	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TRPC6—brain cancer	0.000222	0.0028	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—SMO—brain cancer	0.000218	0.00275	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—PTCH1—brain cancer	0.000218	0.00275	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.00021	0.00265	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000206	0.0026	CbGpPWpGaD
Erythromycin—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000204	0.00257	CbGpPWpGaD
Erythromycin—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000201	0.00253	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—PIK3CG—brain cancer	0.000197	0.00248	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—PIK3CG—brain cancer	0.000179	0.00225	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—NOTCH2—brain cancer	0.000174	0.0022	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000167	0.00211	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—VAV1—brain cancer	0.000166	0.0021	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.000163	0.00205	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000163	0.00205	CbGpPWpGaD
Erythromycin—ABCC1—Disease—DTX2—brain cancer	0.000162	0.00204	CbGpPWpGaD
Erythromycin—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000157	0.00198	CbGpPWpGaD
Erythromycin—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000155	0.00196	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000151	0.0019	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—HES1—brain cancer	0.000143	0.0018	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—IL2—brain cancer	0.000138	0.00175	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—PDGFRA—brain cancer	0.000136	0.00172	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000136	0.00171	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—SPP1—brain cancer	0.000132	0.00167	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000129	0.00162	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—IL2—brain cancer	0.000126	0.00159	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000121	0.00153	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000121	0.00153	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—IRS2—brain cancer	0.00012	0.00151	CbGpPWpGaD
Erythromycin—ABCC1—Disease—HES5—brain cancer	0.000119	0.0015	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000112	0.00142	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000109	0.00138	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000109	0.00138	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000109	0.00137	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—PIK3CG—brain cancer	0.000106	0.00133	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—APC—brain cancer	0.000106	0.00133	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—CYP2C9—brain cancer	0.000102	0.00129	CbGpPWpGaD
Erythromycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	0.000102	0.00128	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—EGFR—brain cancer	9.62e-05	0.00121	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	9.28e-05	0.00117	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—CYP2C9—brain cancer	9.18e-05	0.00116	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	8.92e-05	0.00112	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL2—brain cancer	8.88e-05	0.00112	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	8.74e-05	0.0011	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	8.71e-05	0.0011	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—BSG—brain cancer	8.67e-05	0.00109	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	8.63e-05	0.00109	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	8.54e-05	0.00108	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	8.35e-05	0.00105	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	8.35e-05	0.00105	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—RELA—brain cancer	8.25e-05	0.00104	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—ERBB2—brain cancer	8.2e-05	0.00103	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	8.03e-05	0.00101	CbGpPWpGaD
Erythromycin—ABCC1—Disease—IDH1—brain cancer	8.01e-05	0.00101	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—CYP2C9—brain cancer	8e-05	0.00101	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.83e-05	0.000986	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—BSG—brain cancer	7.8e-05	0.000983	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	7.65e-05	0.000964	CbGpPWpGaD
Erythromycin—ABCC1—Disease—HEY1—brain cancer	7.59e-05	0.000957	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—VEGFA—brain cancer	7.54e-05	0.000951	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—IDH1—brain cancer	7.46e-05	0.00094	CbGpPWpGaD
Erythromycin—ABCC1—Disease—DLL1—brain cancer	7.45e-05	0.000939	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—IL2—brain cancer	7.43e-05	0.000936	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CCND1—brain cancer	7.24e-05	0.000913	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CTNNB1—brain cancer	7.17e-05	0.000904	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—BSG—brain cancer	6.8e-05	0.000858	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—IDH1—brain cancer	6.71e-05	0.000846	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	6.61e-05	0.000833	CbGpPWpGaD
Erythromycin—ABCC1—Disease—SHH—brain cancer	6.33e-05	0.000798	CbGpPWpGaD
Erythromycin—ABCC1—Disease—ENO2—brain cancer	6.33e-05	0.000798	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—VEGFA—brain cancer	6.31e-05	0.000796	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—STAT3—brain cancer	6.25e-05	0.000788	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	6.22e-05	0.000785	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.07e-05	0.000765	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CYP2C9—brain cancer	5.92e-05	0.000746	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—ENO2—brain cancer	5.89e-05	0.000743	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—IDH1—brain cancer	5.85e-05	0.000738	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—MYC—brain cancer	5.81e-05	0.000732	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CYP2C9—brain cancer	5.79e-05	0.000729	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.72e-05	0.000721	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—EGFR—brain cancer	5.68e-05	0.000716	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.46e-05	0.000689	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—ENO2—brain cancer	5.3e-05	0.000668	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	5.19e-05	0.000655	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—BSG—brain cancer	5.03e-05	0.000634	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—BSG—brain cancer	4.92e-05	0.00062	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	4.83e-05	0.000609	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TP53—brain cancer	4.77e-05	0.000601	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—ENO2—brain cancer	4.63e-05	0.000583	CbGpPWpGaD
Erythromycin—ABCC1—Disease—VAV1—brain cancer	4.58e-05	0.000577	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CYP2C9—brain cancer	4.37e-05	0.00055	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—IDH1—brain cancer	4.33e-05	0.000545	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	4.27e-05	0.000538	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—IDH1—brain cancer	4.23e-05	0.000533	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	4.23e-05	0.000533	CbGpPWpGaD
Erythromycin—ABCC1—Disease—HES1—brain cancer	3.93e-05	0.000496	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PDGFRA—brain cancer	3.75e-05	0.000472	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	3.72e-05	0.000469	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—BSG—brain cancer	3.71e-05	0.000468	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CYP2C9—brain cancer	3.48e-05	0.000439	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.42e-05	0.000432	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ENO2—brain cancer	3.42e-05	0.000431	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.35e-05	0.000422	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ENO2—brain cancer	3.34e-05	0.000421	CbGpPWpGaD
Erythromycin—ABCC1—Disease—IRS2—brain cancer	3.29e-05	0.000415	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—IDH1—brain cancer	3.19e-05	0.000402	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—BSG—brain cancer	2.96e-05	0.000373	CbGpPWpGaD
Erythromycin—ABCC1—Disease—APC—brain cancer	2.91e-05	0.000366	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.81e-05	0.000355	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PIK3CG—brain cancer	2.7e-05	0.000341	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CYP2C9—brain cancer	2.69e-05	0.000339	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—IDH1—brain cancer	2.55e-05	0.000321	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—ENO2—brain cancer	2.52e-05	0.000318	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PIK3CG—brain cancer	2.43e-05	0.000307	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—BSG—brain cancer	2.29e-05	0.000288	CbGpPWpGaD
Erythromycin—ABCC1—Disease—ERBB2—brain cancer	2.26e-05	0.000284	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PIK3CG—brain cancer	2.12e-05	0.000267	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.07e-05	0.000262	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ENO2—brain cancer	2.01e-05	0.000254	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CTNNB1—brain cancer	1.97e-05	0.000249	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—IDH1—brain cancer	1.97e-05	0.000248	CbGpPWpGaD
Erythromycin—ABCC1—Disease—STAT3—brain cancer	1.72e-05	0.000217	CbGpPWpGaD
Erythromycin—ABCC1—Disease—MYC—brain cancer	1.6e-05	0.000201	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PIK3CG—brain cancer	1.57e-05	0.000198	CbGpPWpGaD
Erythromycin—ABCC1—Disease—EGFR—brain cancer	1.56e-05	0.000197	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ENO2—brain cancer	1.55e-05	0.000196	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PIK3CG—brain cancer	1.53e-05	0.000193	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PIK3CG—brain cancer	1.16e-05	0.000146	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PIK3CG—brain cancer	9.24e-06	0.000116	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PIK3CG—brain cancer	7.13e-06	8.99e-05	CbGpPWpGaD
